|
| | | CD138 immunhistochemistry results (%) |
| Entity | on TMA | analyzable | Negative % | Weak % | Moderate % | Strong % | Positive % |
|
Tumors of the skin | Pilomatrixoma | 35 | 30 | 63.3 | 26.7 | 10.0 | 0.0 | 36.7 |
Basalioma | 48 | 41 | 2.4 | 7.3 | 7.3 | 82.9 | 97.6 |
Epidermal nevus | 29 | 19 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cutaneous squamous cell carcinoma | 50 | 42 | 7.1 | 21.4 | 9.5 | 61.9 | 92.9 |
Malignant melanoma | 48 | 39 | 97.4 | 2.6 | 0.0 | 0.0 | 2.6 |
Merkel cell carcinoma | 46 | 42 | 69.0 | 21.4 | 2.4 | 7.1 | 31.0 |
|
Tumors of the airway | Laryngeal squamous cell carcinoma | 50 | 44 | 15.9 | 31.8 | 11.4 | 40.9 | 84.1 |
Oral squamous cell carcinoma | 50 | 45 | 11.1 | 22.2 | 20.0 | 46.7 | 88.9 |
Lung squamous cell carcinoma | 50 | 21 | 14.3 | 14.3 | 9.5 | 61.9 | 85.7 |
Large cell bronchial carcinoma | 31 | 25 | 56.0 | 32.0 | 4.0 | 8.0 | 44.0 |
Lung adenocarcinoma | 50 | 35 | 17.1 | 34.3 | 20.0 | 28.6 | 82.9 |
Lung in situ pulmonary adenocarcinoma | 6 | 15 | 80.0 | 20.0 | 0.0 | 0.0 | 20.0 |
Lung small cell carcinoma | 20 | 5 | 20.0 | 20.0 | 40.0 | 20.0 | 80.0 |
Malignant mesothelioma | 48 | 35 | 97.1 | 2.9 | 0.0 | 0.0 | 2.9 |
Parotid gland pleomorphic adenoma | 50 | 37 | 21.6 | 10.8 | 18.9 | 48.6 | 78.4 |
Parotid gland Warthin tumor | 49 | 41 | 7.3 | 29.3 | 22.0 | 41.5 | 92.7 |
Salivary gland Basal cell adenoma | 15 | 15 | 0.0 | 33.3 | 33.3 | 33.3 | 100.0 |
|
Gynecological tumors | Vagina squamous cell carcinoma | 48 | 29 | 10.3 | 27.6 | 24.1 | 37.9 | 89.7 |
Vulva squamous cell carcinoma | 50 | 30 | 26.7 | 13.3 | 33.3 | 26.7 | 73.3 |
Cervix squamous cell carcinoma | 50 | 39 | 20.5 | 23.1 | 25.6 | 30.8 | 79.5 |
Cervix adenocarcinoma | 50 | 41 | 85.4 | 14.6 | 0.0 | 0.0 | 14.6 |
Endometrial carcinoma endometrioid | 50 | 44 | 72.7 | 13.6 | 11.4 | 2.3 | 27.3 |
Endometrial carcinoma serous | 50 | 33 | 60.6 | 9.1 | 18.2 | 12.1 | 39.4 |
Uterus stromal sarcoma | 12 | 10 | 90.0 | 0.0 | 10.0 | 0.0 | 10.0 |
Carcinosarcoma | 48 | 47 | 74.5 | 12.8 | 8.5 | 4.3 | 25.5 |
Ovarian carcinoma endometrioid | 37 | 30 | 56.7 | 16.7 | 6.7 | 20.0 | 43.3 |
Ovarian carcinoma serous | 50 | 39 | 79.5 | 10.3 | 7.7 | 2.6 | 20.5 |
Ovarian carcinoma mucinous | 26 | 21 | 33.3 | 19.0 | 0.0 | 47.6 | 66.7 |
Brenner tumor | 9 | 6 | 0.0 | 0.0 | 0.0 | 100.0 | 100.0 |
NST breast carcinoma | 46 | 28 | 46.4 | 17.9 | 7.1 | 28.6 | 53.6 |
Lobular breast carcinoma | 43 | 27 | 74.1 | 11.1 | 7.4 | 7.4 | 25.9 |
Medullary breast carcinoma | 15 | 11 | 72.7 | 9.1 | 9.1 | 9.1 | 27.3 |
Tubular breast carcinoma | 18 | 10 | 40.0 | 10.0 | 10.0 | 40.0 | 60.0 |
Mucinous breast carcinoma | 22 | 14 | 64.3 | 28.6 | 0.0 | 7.1 | 35.7 |
Phyllodes breast tumor | 50 | 18 | 5.6 | 22.2 | 38.9 | 33.3 | 94.4 |
|
Gastrointestinal tumors | Colon adenoma, low grade | 50 | 27 | 0.0 | 3.7 | 3.7 | 92.6 | 100.0 |
Colon adenoma, high grade | 50 | 25 | 0.0 | 4.0 | 4.0 | 92.0 | 100.0 |
Colon adenocarcinoma | 50 | 34 | 14.7 | 35.3 | 20.6 | 29.4 | 85.3 |
Small intestine adenocarcinoma | 10 | 4 | 75.0 | 25.0 | 0.0 | 0.0 | 25.0 |
Stomach carcinoma diffuse type | 50 | 24 | 45.8 | 16.7 | 8.3 | 29.2 | 54.2 |
Stomach carcinoma intestinal type | 50 | 28 | 21.4 | 42.9 | 14.3 | 21.4 | 78.6 |
Esophageal adenocarcinoma | 50 | 33 | 30.3 | 27.3 | 12.1 | 30.3 | 69.7 |
Esophageal squamous cell carcinoma | 49 | 33 | 0.0 | 12.1 | 9.1 | 78.8 | 100.0 |
Anal squamous cell carcinoma | 50 | 22 | 9.1 | 18.2 | 9.1 | 63.6 | 90.9 |
Cholangiocarcinoma | 50 | 23 | 60.9 | 17.4 | 8.7 | 13.0 | 39.1 |
Hepatocellular carcinoma | 50 | 44 | 2.3 | 15.9 | 9.1 | 72.7 | 97.7 |
Pancreatic ductal adenocarcinoma | 50 | 30 | 26.7 | 36.7 | 16.7 | 20.0 | 73.3 |
Pancreas/papilla adenocarcinoma | 30 | 17 | 29.4 | 17.6 | 11.8 | 41.2 | 70.6 |
Pancreatic neuroendocrine tumor | 49 | 28 | 82.1 | 3.6 | 3.6 | 10.7 | 17.9 |
Gastrointestinal stroma tumor (GIST) | 50 | 37 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 |
|
Urogenital tumors | Urothelial carcinoma pTa | 50 | 41 | 12.2 | 2.4 | 4.9 | 80.5 | 87.8 |
Urothelial carcinoma T2-4 | 50 | 42 | 23.8 | 4.8 | 16.7 | 54.8 | 76.2 |
Small cell urothelial carcinoma | 18 | 18 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Clear cell renal cell carcinoma | 50 | 46 | 45.7 | 13.0 | 17.4 | 23.9 | 54.3 |
Papillary renal cell carcinoma | 50 | 44 | 59.1 | 22.7 | 6.8 | 11.4 | 40.9 |
Chromophobe renal cell carcinoma | 50 | 42 | 81.0 | 9.5 | 9.5 | 0.0 | 19.0 |
Renal oncocytoma | 50 | 44 | 38.6 | 27.3 | 20.5 | 13.6 | 61.4 |
Prostate carcinoma | 49 | 43 | 83.7 | 4.7 | 4.7 | 7.0 | 16.3 |
Small cell prostate carcinoma | 17 | 11 | 54.5 | 27.3 | 9.1 | 9.1 | 45.5 |
Seminoma | 50 | 47 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Embryonic carcinoma (testis) | 50 | 39 | 97.4 | 2.6 | 0.0 | 0.0 | 2.6 |
Yolk sac tumor | 50 | 25 | 92.0 | 4.0 | 4.0 | 0.0 | 8.0 |
Teratoma | 50 | 23 | 17.4 | 4.3 | 8.7 | 69.6 | 82.6 |
|
Endocrine tumors | Thyroid adenoma | 50 | 45 | 80.0 | 13.3 | 2.2 | 4.4 | 20.0 |
Papillary thyroid carcinoma | 50 | 36 | 63.9 | 8.3 | 13.9 | 13.9 | 36.1 |
Follicular thyroid carcinoma | 49 | 44 | 77.3 | 9.1 | 6.8 | 6.8 | 22.7 |
Medullary thyroid carcinoma | 50 | 29 | 82.8 | 3.4 | 0.0 | 13.8 | 17.2 |
Anaplastic thyroid carcinoma | 26 | 19 | 89.5 | 5.3 | 0.0 | 5.3 | 10.5 |
Adrenal adenoma | 50 | 48 | 72.9 | 10.4 | 6.3 | 10.4 | 27.1 |
Adrenal carcinoma | 26 | 14 | 35.7 | 21.4 | 14.3 | 28.6 | 64.3 |
Pheochromocytoma | 50 | 32 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Neuroendocrine tumor (NET) | 50 | 27 | 81.5 | 7.4 | 7.4 | 3.7 | 18.5 |
|
Hemic neoplasia | Hodgkin lymphoma | 45 | 43 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Non-Hodgkin lymphoma | 48 | 42 | 97.6 | 2.4 | 0.0 | 0.0 | 2.4 |
Thymoma | 29 | 24 | 70.8 | 16.7 | 8.3 | 4.2 | 29.2 |
|
Soft tissue tumors | Giant cell-long sheath tumor | 45 | 41 | 97.6 | 2.4 | 0.0 | 0.0 | 2.4 |
Granular cell tumor | 30 | 24 | 0.0 | 12.5 | 25.0 | 62.5 | 100.0 |
Leiomyoma | 50 | 41 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Leiomyosarcoma | 49 | 46 | 93.5 | 0.0 | 6.5 | 0.0 | 6.5 |
Liposarcoma | 49 | 34 | 97.1 | 2.9 | 0.0 | 0.0 | 2.9 |
Angiosarcoma | 32 | 22 | 90.9 | 4.5 | 4.5 | 0.0 | 9.1 |
|
Bone neoplasm | Osteosarcoma | 25 | 17 | 88.2 | 5.9 | 5.9 | 0.0 | 11.8 |
Chondrosarcoma | 25 | 8 | 87.5 | 0.0 | 12.5 | 0.0 | 12.5 |
|